149 related articles for article (PubMed ID: 22170592)
1. Study of the anticancer properties of tin(IV) carboxylate complexes on a panel of human tumor cell lines.
Rocamora-Reverte L; Carrasco-García E; Ceballos-Torres J; Prashar S; Kaluđerović GN; Ferragut JA; Gómez-Ruiz S
ChemMedChem; 2012 Feb; 7(2):301-10. PubMed ID: 22170592
[TBL] [Abstract][Full Text] [Related]
2. Study of the cytotoxic activity of di and triphenyltin(IV) carboxylate complexes.
Gómez-Ruiz S; Kaluderović GN; Prashar S; Hey-Hawkins E; Erić A; Zizak Z; Juranić ZD
J Inorg Biochem; 2008 Dec; 102(12):2087-96. PubMed ID: 18760840
[TBL] [Abstract][Full Text] [Related]
3. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, molecular structure and evaluation of new organometallic ruthenium anticancer agents.
Camm KD; El-Sokkary A; Gott AL; Stockley PG; Belyaeva T; McGowan PC
Dalton Trans; 2009 Dec; (48):10914-25. PubMed ID: 20023922
[TBL] [Abstract][Full Text] [Related]
5. The triphenyltin(VI) complexes of NSAIDs and derivatives. Synthesis, crystal structure and antiproliferative activity. Potent anticancer agents.
Dokorou V; Primikiri A; Kovala-Demertzi D
J Inorg Biochem; 2011 Feb; 105(2):195-201. PubMed ID: 21194618
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic salan-titanium(IV) complexes: high activity toward a range of sensitive and drug-resistant cell lines, and mechanistic insights.
Manna CM; Braitbard O; Weiss E; Hochman J; Tshuva EY
ChemMedChem; 2012 Apr; 7(4):703-8. PubMed ID: 22262543
[TBL] [Abstract][Full Text] [Related]
7. Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines.
Roomi MW; Kalinovsky T; Roomi NW; Rath M; Niedzwiecki A
Oncol Rep; 2012 Jan; 27(1):17-27. PubMed ID: 21947138
[TBL] [Abstract][Full Text] [Related]
8. An in vitro and in vivo study of a novel zinc complex, zinc N-(2-hydroxyacetophenone)glycinate to overcome multidrug resistance in cancer.
Ghosh RD; Das S; Ganguly A; Banerjee K; Chakraborty P; Sarkar A; Chatterjee M; Nanda A; Pradhan K; Choudhuri SK
Dalton Trans; 2011 Nov; 40(41):10873-84. PubMed ID: 21717020
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of platinum(IV) anticancer drugs with functionalized aromatic carboxylate ligands: influence of the ligands on drug efficacies and uptake.
Ang WH; Pilet S; Scopelliti R; Bussy F; Juillerat-Jeanneret L; Dyson PJ
J Med Chem; 2005 Dec; 48(25):8060-9. PubMed ID: 16335930
[TBL] [Abstract][Full Text] [Related]
10. Copper(II) complexes of salicylic acid combining superoxide dismutase mimetic properties with DNA binding and cleaving capabilities display promising chemotherapeutic potential with fast acting in vitro cytotoxicity against cisplatin sensitive and resistant cancer cell lines.
O'Connor M; Kellett A; McCann M; Rosair G; McNamara M; Howe O; Creaven BS; McClean S; Kia AF; O'Shea D; Devereux M
J Med Chem; 2012 Mar; 55(5):1957-68. PubMed ID: 22313179
[TBL] [Abstract][Full Text] [Related]
11. A new class of antitumor trans-amine-amidine-Pt(II) cationic complexes: influence of chemical structure and solvent on in vitro and in vivo tumor cell proliferation.
Marzano C; Mazzega Sbovata S; Gandin V; Colavito D; Del Giudice E; Michelin RA; Venzo A; Seraglia R; Benetollo F; Schiavon M; Bertani R
J Med Chem; 2010 Aug; 53(16):6210-27. PubMed ID: 20681543
[TBL] [Abstract][Full Text] [Related]
12. [NiII(3-OMe-salophene)]: a potent agent with antitumor activity.
Lee SY; Hille A; Frias C; Kater B; Bonitzki B; Wölfl S; Scheffler H; Prokop A; Gust R
J Med Chem; 2010 Aug; 53(16):6064-70. PubMed ID: 20669965
[TBL] [Abstract][Full Text] [Related]
13. Anticancer activity of dinuclear gallium(III) carboxylate complexes.
Kaluderović MR; Gómez-Ruiz S; Gallego B; Hey-Hawkins E; Paschke R; Kaluderović GN
Eur J Med Chem; 2010 Feb; 45(2):519-25. PubMed ID: 19926362
[TBL] [Abstract][Full Text] [Related]
14. Ferrocenylselenoamides: synthesis, characterization and cytotoxic properties.
Gutiérrez-Hernández AI; López-Cortés JG; Ortega-Alfaro MC; Ramírez-Apan MT; Cázares-Marinero Jde J; Toscano RA
J Med Chem; 2012 May; 55(10):4652-63. PubMed ID: 22524555
[TBL] [Abstract][Full Text] [Related]
15. Synergetic anticancer activity of gold porphyrin appended to phenyl tin malonate organometallic complexes.
Nguyen C; Toubia I; Diring S; Hadj-Kaddour K; Gary-Bobo M; Kobeissi M; Odobel F
Dalton Trans; 2021 Apr; 50(13):4583-4592. PubMed ID: 33705511
[TBL] [Abstract][Full Text] [Related]
16. Platinum(II) and palladium(II) complexes with (N,N') and (C,N,N')- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities.
Quirante J; Ruiz D; Gonzalez A; López C; Cascante M; Cortés R; Messeguer R; Calvis C; Baldomà L; Pascual A; Guérardel Y; Pradines B; Font-Bardía M; Calvet T; Biot C
J Inorg Biochem; 2011 Dec; 105(12):1720-8. PubMed ID: 22104300
[TBL] [Abstract][Full Text] [Related]
17. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
[TBL] [Abstract][Full Text] [Related]
18. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.
Pellei M; Papini G; Trasatti A; Giorgetti M; Tonelli D; Minicucci M; Marzano C; Gandin V; Aquilanti G; Dolmella A; Santini C
Dalton Trans; 2011 Oct; 40(38):9877-88. PubMed ID: 21709917
[TBL] [Abstract][Full Text] [Related]
19. Self-assembly of novel molecular complexes of 1,10-phenanthroline and 5-amino-1,10-phenanthroline and evaluation of their in vitro antitumour activity.
Kaloyanov N; Alexandrova R; Wesselinova DW; Mayer-Figge H; Sheldrick WS; Dimitrov GD
Eur J Med Chem; 2011 Jun; 46(6):1992-6. PubMed ID: 21474217
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of structure-activity relationships between salphen metal complexes and human telomeric DNA quadruplexes.
Campbell NH; Karim NH; Parkinson GN; Gunaratnam M; Petrucci V; Todd AK; Vilar R; Neidle S
J Med Chem; 2012 Jan; 55(1):209-22. PubMed ID: 22112241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
